If a person can consistently uses a strain that ameliorates their symptoms, they won't have any issue.
What has happened, though is the legal BS around medical and the law imposed by the federal government make it hard for users to know much more about a strain than it heritage, thc content, and usually some every basic CBD percentage info. There are other factors at play that are completely unaware of or possible have some vague idea about.
The laws surrounding lab analysis disclosures need to be beefed up to include terpene percentages and the dispensaries need to provide information about the strain just the way a pharmacy does, with a one-sheet listing everything in it and what it may do.
The fed and dea will try their best to spin this into reefer madness again.
I put this at the feet of the US drug policy.
If a person can consistently uses a strain that ameliorates their symptoms, they won't have any issue.
What has happened, though is the legal BS around medical and the law imposed by the federal government make it hard for users to know much more about a strain than it heritage, thc content, and usually some every basic CBD percentage info. There are other factors at play that are completely unaware of or possible have some vague idea about.
The laws surrounding lab analysis disclosures need to be beefed up to include terpene percentages and the dispensaries need to provide information about the strain just the way a pharmacy does, with a one-sheet listing everything in it and what it may do.
The fed and dea will try their best to spin this into reefer madness again.
I put this at the feet of the US drug policy.
If a person can consistently uses a strain that ameliorates their symptoms, they won't have any issue.
What has happened, though is the legal BS around medical and the law imposed by the federal government make it hard for users to know much more about a strain than it heritage, thc content, and usually some every basic CBD percentage info. There are other factors at play that are completely unaware of or possible have some vague idea about.
The laws surrounding lab analysis disclosures need to be beefed up to include terpene percentages and the dispensaries need to provide information about the strain just the way a pharmacy does, with a one-sheet listing everything in it and what it may do.
The fed and dea will try their best to spin this into reefer madness again.